{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:35:43Z","timestamp":1793072143577,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.brachy.2020.06.011","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T08:37:40Z","timestamp":1594802260000},"page":"574-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy"],"prefix":"10.1016","volume":"19","author":[{"given":"David","family":"Boyce-Fappiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharakeswara K.","family":"Bathala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Pasalic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olsi","family":"Gjyshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Pezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal S.","family":"Noticewala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8880-5062","authenticated-orcid":false,"given":"Gwendolyn J.","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Maroongroge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Kuban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh-Nhu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean E.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungtaek","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat J.","family":"Kudchadker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-7884","authenticated-orcid":false,"given":"Steven J.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2020.06.011_bib3","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after Monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2020.06.011_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.brachy.2012.04.002","article-title":"Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low\/intermediate prostate cancer","volume":"11","author":"Shah","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.06.011_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijrobp.2017.09.050","article-title":"Prospective Phase 2 trial of permanent seed implantation prostate brachytherapy for intermediate-risk localized prostate cancer: Efficacy, toxicity, and quality of life outcomes","volume":"100","author":"Frank","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2020.06.011_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2020.06.011_bib7","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ijrobp.2016.06.026","article-title":"Initial report of NRG Oncology\/RTOG 0232: a Phase 3 study comparing combined external beam radiation and transperineal Interstitial permanent brachytherapy with brachytherapy Alone for selected patients with intermediate-risk prostatic carcinoma","volume":"96","author":"Prestidge","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2020.06.011_bib8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.109.192695","article-title":"Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart association, American cancer Society, and American urological association: endorsed by the American Society for radiation Oncology","volume":"121","author":"Levine","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.brachy.2020.06.011_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: an analysis of treatment-related morbidity for a Randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brachy.2013.08.005","article-title":"Declining use of brachytherapy for the treatment of prostate cancer","volume":"13","author":"Mahmood","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.06.011_bib12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.brachy.2016.11.012","article-title":"Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow","volume":"16","author":"Blanchard","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.06.011_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brachy.2012.03.009","article-title":"Magnetic resonance imaging-based treatment planning for prostate brachytherapy","volume":"12","author":"Albert","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.06.011_bib14","first-page":"235","article-title":"Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience","volume":"8","author":"Lim","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2020.06.011_bib15","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.brachy.2019.04.169","article-title":"Defining the value of MRI-assisted radiosurgery (MARS) for prostate brachytherapy: a Pilot study using time-Driven Activity-based costing","volume":"18","author":"Thaker","year":"2019","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.brachy.2020.06.011_bib16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/nau.20768","article-title":"Cadaveric study of nerves supplying the membranous urethra","volume":"29","author":"Song","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.brachy.2020.06.011_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11934-017-0717-4","article-title":"Surgical techniques to optimize Early urinary continence recovery post Robot assisted radical prostatectomy for prostate cancer","volume":"18","author":"Sridhar","year":"2017","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.brachy.2020.06.011_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.eururo.2016.06.023","article-title":"Preoperative membranous urethral length Measurement and continence recovery following radical prostatectomy: a Systematic review and Meta-analysis","volume":"71","author":"Mungovan","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2020.06.011_bib19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eururo.2015.07.037","article-title":"Nerve-sparing surgery technique, not the preservation of the Neurovascular bundles, leads to improved long-term continence rates after radical prostatectomy","volume":"69","author":"Michl","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2020.06.011_bib20","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/S0022-5347(01)62202-X","article-title":"Anatomic radical prostatectomy","volume":"160","author":"Walsh","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2020.06.011_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.brachy.2015.04.004","article-title":"High-dose-rate brachytherapy boost for prostate cancer: outcomes and genitourinary toxicity","volume":"14","author":"Bece","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.06.011_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0360-3016(01)01811-9","article-title":"The dosimetry of prostate brachytherapy-induced urethral strictures","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2012.06.001","article-title":"Correlation between prostate brachytherapy-related urethral stricture and peri-apical urethral dosimetry: a matched case-control study","volume":"104","author":"Earley","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2020.06.011_bib24","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) Common Terminology Criteria for Adverse Events (CTCAE) v5.0","author":"National","year":"2017"},{"key":"10.1016\/j.brachy.2020.06.011_bib25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0090-4295(02)01840-X","article-title":"Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy","volume":"60","author":"Merrick","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2020.06.011_bib26","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 Consecutive patients","volume":"73","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brachy.2013.10.005","article-title":"Decline in acute urinary toxicity: a long-term study in 2011 patients with prostate brachytherapy within a provincial institution","volume":"13","author":"Chan","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.06.011_bib28","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0360-3016(03)00210-4","article-title":"Urinary symptom flare following I-125 prostate brachytherapy","volume":"56","author":"Cesaretti","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.brachy.2015.12.011","article-title":"Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy","volume":"15","author":"Eriguchi","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.06.011_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0360-3016(99)00525-8","article-title":"Temporal resolution of urinary morbidity following prostate brachytherapy","volume":"47","author":"Merrick","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0360-3016(99)00176-5","article-title":"Urinary morbidity following ultrasound-guided transperineal prostate seed implantation","volume":"45","author":"Gelblum","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1200\/JCO.1996.14.2.449","article-title":"Tumor control and morbidity following transperineal iodine 125 implantation for stage T1\/T2 prostatic carcinoma","volume":"14","author":"Wallner","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2020.06.011_bib33","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0360-3016(01)01530-9","article-title":"Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method","volume":"50","author":"Kang","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00130404-200405000-00008","article-title":"The impact of prostate volume and neoadjuvant androgen-deprivation therapy on urinary function following prostate brachytherapy","volume":"10","author":"Merrick","year":"2004","journal-title":"Cancer J"},{"key":"10.1016\/j.brachy.2020.06.011_bib35","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.ijrobp.2016.03.047","article-title":"Time Course and Accumulated risk of severe urinary Adverse Events after high- versus low-dose-rate prostate brachytherapy with or without external beam radiation therapy","volume":"95","author":"Tward","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0360-3016(03)00640-0","article-title":"Rtog 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?","volume":"57","author":"Valicenti","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib37","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.urology.2007.11.067","article-title":"Does timing of androgen deprivation Influence radiation-induced toxicity? A secondary analysis of radiation therapy Oncology group protocol 9413","volume":"72","author":"Taussky","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2020.06.011_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0090-4295(99)00122-3","article-title":"Complications after prostate brachytherapy in the Medicare population","volume":"55","author":"Benoit","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2020.06.011_bib39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijrobp.2017.09.050","article-title":"Clinical Investigation prospective Phase 2 trial of permanent seed implantation prostate brachytherapy for intermediate-risk localized prostate cancer: Efficacy, toxicity, and quality of life outcomes radiation Oncology","volume":"100","author":"Frank","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib40","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ijrobp.2004.01.050","article-title":"Factors predicting for urinary incontinence after prostate brachytherapy","volume":"59","author":"McElveen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib41","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0360-3016(02)04600-X","article-title":"Long-term urinary quality of life after permanent prostate brachytherapy","volume":"56","author":"Merrick","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib42","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijrobp.2014.06.037","article-title":"Late urinary side effects 10 years after low-dose-rate prostate brachytherapy: population-based results from a multiphysician practice treating with a standardized protocol and uniform dosimetric goals","volume":"90","author":"Keyes","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijrobp.2007.12.052","article-title":"Segmental urethral dosimetry and urinary toxicity in patients with No urinary symptoms before permanent prostate brachytherapy","volume":"72","author":"Thomas","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brachy.2005.01.002","article-title":"Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at risk","volume":"4","author":"Crook","year":"2005","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2020.06.011_bib45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0360-3016(94)00599-G","article-title":"Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy","volume":"32","author":"Wallner","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib46","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0360-3016(02)04142-1","article-title":"Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy","volume":"55","author":"Zelefsky","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2020.06.011_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0090-4295(02)02142-8","article-title":"Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy","volume":"61","author":"Elshaikh","year":"2003","journal-title":"Urology"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847212030129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847212030129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:15:35Z","timestamp":1761531335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153847212030129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S153847212030129X"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2020.06.011","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2020.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}